#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Facioscapulohumeral muscular dystrophy Carcinoid tumour Cutaneous T-cell lymphoma recurrent Alport's syndrome Neurodegenerative disorder Leiomyosarcoma metastatic Thrombocytopenia Retinal artery occlusion Haemophilia A with anti factor VIII Adenocarcinoma pancreas Arrhythmia Herpes simplex Vulval cancer Spina bifida Cardiac amyloidosis More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Treatment Mucopolysaccharidosis II – Diagnostics Mast cell activation syndrome – Treatment Alveolar rhabdomyosarcoma – Trials in Disease Gaucher’s disease type I – Trials in Disease Medulloblastoma recurrent – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Treatment Osteosarcoma metastatic – Life with Disease Mast cell activation syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lorazepam Delandistrogene Moxeparvovec Pilocarpine Nitrate Darolutamide Dasatinib Midazolam Hydrochloride Selatogrel Betamethasone Valerate Rifapentine Bt8009 Leuprorelin Acetate Sodium Gluconate Vindesine Sulfate Progesterone, Micronised Inupadenant Hydrochloride VISUGROMAB Brentuximab Vedotin Amantadine Hemisulfate Pivekimab Sunirine Regn5668 More therapies…

    Learn about Your Condition

    Back pain Breast conserving surgery Gastric cancer stage IV T-cell type acute leukaemia Nodal osteoarthritis Diabetic neuropathy Systemic mastocytosis Lymphangiosarcoma Transferrin decreased Congenital myopathy Angiosarcoma recurrent Hyperplasia adrenal Developmental hip dysplasia Pustular psoriasis Vascular malformation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary hypertension

  • Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Sotatercept
    Belgium France Germany Italy Poland Spain +1

  • Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Macitentan
    France

  • Study on the Safety and Effectiveness of Apixaban, Edoxaban, and Phenprocoumon for Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism
    • Pulmonary hypertension
    Investigated Drugs:
    • Acenocoumarol
    • Dabigatran Etexilate
    • Phenprocoumon
    The Netherlands

  • Study on the Effects of Riociguat in Patients with Pulmonary Hypertension Due to Left Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Riociguat
    Czechia Germany Italy

  • Study on Treprostinil Palmitil Inhalation Powder for Patients with Pulmonary Hypertension and Interstitial Lung Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Treprostinil Palmitil
    Belgium Germany Italy Spain

  • Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Ralinepag
    Austria Belgium Bulgaria Czechia Denmark France +9
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!